News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
GammaCan International, Inc., Announces Appointment Of Lynn Schuchter M.D. To Its Scientific Advisory Board
October 31, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
KIRYAT ONO, Israel & NEW YORK--(BUSINESS WIRE)--GammaCan International, Inc.(OTC BB: GCAN) today announced the appointment of Lynn Schuchter M.D. to the Company’s Scientific Advisory Board.
Twitter
LinkedIn
Facebook
Email
Print
People
Asia
MORE ON THIS TOPIC
Startups
AI-Focused Biotech Unicorns Face Chilly Market Where IPOs Aren’t Guaranteed
July 16, 2025
·
14 min read
·
Tristan Manalac
Leadership
5 Women Biotech Leaders Bagging Billions in M&A Dollars
July 16, 2025
·
8 min read
·
Tristan Manalac
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
·
6 min read
·
Lori Ellis
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
·
1 min read
·
Dan Samorodnitsky
